» Articles » PMID: 29736023

MC4R Agonism Promotes Durable Weight Loss in Patients with Leptin Receptor Deficiency

Abstract

Genetic defects underlying the melanocortin-4 receptor (MC4R) signaling pathway lead to severe obesity. Three severely obese LEPR-deficient individuals were administered the MC4R agonist setmelanotide, resulting in substantial and durable reductions in hyperphagia and body weight over an observation period of 45-61 weeks. Compared to formerly developed and tested MC4R agonists, setmelanotide has the unique capability of activating nuclear factor of activated T cell (NFAT) signaling and restoring function of this signaling pathway for selected MC4R variants. Our data demonstrate the potency of setmelanotide in treatment of individuals with diverse MC4R-related pathway deficiencies.

Citing Articles

GPCRs in hypothalamic neurons and their roles in controlling food intake and metabolism.

Qiu T, Fu O Front Mol Neurosci. 2025; 18:1536577.

PMID: 39974186 PMC: 11835808. DOI: 10.3389/fnmol.2025.1536577.


Raptin, a sleep-induced hypothalamic hormone, suppresses appetite and obesity.

Xie L, Hu B, Lu R, Cheng Y, Chen X, Wen J Cell Res. 2025; 35(3):165-185.

PMID: 39875551 DOI: 10.1038/s41422-025-01078-8.


regulates melanocortin 4 receptor transcription and energy homeostasis.

Xu B, Lawler K, Wyler S, Li L, Swati , Keogh J Sci Transl Med. 2025; 17(781):eadr6459.

PMID: 39813316 PMC: 11797978. DOI: 10.1126/scitranslmed.adr6459.


The expanding landscape of genetic causes of obesity.

Semenova E, Guo A, Liang H, Hernandez C, John E, Thaker V Pediatr Res. 2024; .

PMID: 39690244 DOI: 10.1038/s41390-024-03780-6.


Future Medications for Obesity and Clinical Implications.

Garvey W Diabetes Spectr. 2024; 37(4):325-334.

PMID: 39649698 PMC: 11623045. DOI: 10.2337/dsi24-0004.


References
1.
Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson S . Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem. 1993; 268(20):15174-9. View